127 related articles for article (PubMed ID: 29562499)
1. Potential biomarkers for the early diagnosis of colorectal adenocarcinoma - transcriptomic analysis of four clinical stages.
Janikowska G; Janikowski T; Pyka-Pająk A; Mazurek U; Janikowski M; Gonciarz M; Lorenc Z
Cancer Biomark; 2018; 22(1):89-99. PubMed ID: 29562499
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-related gene expression in colorectal cancer patients.
Bednarczyk M; Muc-Wierzgoń M; Waniczek D; Fatyga E; Klakla K; Mazurek U; Wierzgoń J
J Biol Regul Homeost Agents; 2017; 31(4):923-927. PubMed ID: 29254294
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
4. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
[TBL] [Abstract][Full Text] [Related]
5. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
6. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Perakis SO; Thomas JE; Pichler M
Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
[TBL] [Abstract][Full Text] [Related]
10. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
Bae JM; Kim JH; Kang GH
Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
12. Cell-surface markers for colon adenoma and adenocarcinoma.
Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
[TBL] [Abstract][Full Text] [Related]
13. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
[TBL] [Abstract][Full Text] [Related]
14. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Liu J; Liu F; Li X; Song X; Zhou L; Jie J
Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
16. Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer.
Chen CJ; Sung WW; Chen HC; Chern YJ; Hsu HT; Lin YM; Lin SH; Peck K; Yeh KT
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362321
[TBL] [Abstract][Full Text] [Related]
17. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of ADAM10, ADAM12, ADAM17 AND ADAM28 in colorectal cancer patients.
Walkiewicz K; Nowakowska-Zajdel E; Strzelczyk J; Dzięgielewska-Gęsiak S; Muc-Wierzgoń M
J Biol Regul Homeost Agents; 2017; 31(4):929-934. PubMed ID: 29254295
[TBL] [Abstract][Full Text] [Related]
20. The expression profiles of the galectin gene family in colorectal adenocarcinomas.
Gopalan V; Saremi N; Sullivan E; Kabir S; Lu CT; Salajegheh A; Leung M; Smith RA; Lam AK
Hum Pathol; 2016 Jul; 53():105-13. PubMed ID: 27001434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
